The global yacht insurance market has faced significant challenges...
Category:
Non-Life
Latest
IRDAI forms task force to address challenges and drive growth in surety bond market
Debasish Panda, chairman, IRDAI "Surety bonds play a crucial role...
APAC: Climate change response held back by insufficient data
“The deadly heat waves and catastrophic floods we’ve seen in recent...
Delta variant forces new lockdowns across world as Europe eases curbs
Bangladesh announced that it would impose a new national lockdown from Monday over the variant, with offices shut for a week and only medical-related transport allowed. Sydney’s normally bustling harbourside centre was nearly deserted after people were ordered to stay home except for essential trips.
New Zealand, citing “multiple outbreaks” in Australia, announced a three-day suspension of its quarantine-free travel arrangement with its larger neighbour.
India records 50,040 new COVID-19 cases, Centre presents vaccination roadmap to SC
The active cases constitute about 1.94 per cent of the total cases. Around 32.17 crore vaccine doses have been administered so far under the country’s vaccination drive. 64.25 lakh doses were administered in the last 24 hours.
The government said besides these, over 7.84 crore doses have been administered to persons between 18 to 44 years of age.
“Total 44.2 per cent of the priority population of persons above 45 years of age and 13 per cent of the population group of 18-44 years of age have received the first vaccine dose,” the Centre said in its affidavit filed in the top court in the suo motu matter on COVID-19 management.
Delta + has more affinity for lung tissues: NTAGI chief
“Delta plus is having greater affinity to mucosal lining in the lungs, higher compared to other variants, but if it causes damage or not is not clear yet. It also does not mean that this variant will cause more severe disease or it is more transmissible,” Arora said.
He said the impact of the Delta plus strain will become clear only as more cases are identified but it appears that the disease is generally mild in all those who have got either single or double dose of the vaccine.
Phase 1 of Ola e-scooter factory nearing completion, rollout soon: CEO
The launch of the electric scooter is in line with Ola’s global vision of moving mobility into a more sustainable, accessible and connected future.
“The EV revolution is coming! From Karnataka in 2017 to Gujarat just this week, 21 states and UTs are now incentivising EVs to make them affordable. We’re committed to accelerating this with #OlaFuturefactory and our scooter that’s coming soon,” he had tweeted.
While the company is yet to disclose the pricing and specifications of its e-scooter, Ola has stated that it is working on setting up a ‘Hypercharger Network’ to include one lakh charging points across 400 cities.
Covid-19 survivors may take a year to get back taste, smell: Study
Since the pandemic was declared in early 2020, Covid-19-related anosmia, complete loss of smell, quickly emerged as a telltale sign of infection.
The loss of smell can severely impact a person’s quality of life, making it extremely difficult to taste foods, detect airborne hazards in the environment and carry out other functions dependent on the senses.
PM Modi urges India to get COVID-19 shots amid Delta variant concerns
India must administer 10 million doses a day to achieve its aim of inoculating all adults by December, experts say. But the country has fully vaccinated fewer than 6% with two doses.
Govt extends I-T compliance deadlines; exempts tax on COVID treatment cost, ex-gratia payments from employers
“In order to ensure that no income tax liability arises on this account, it has been decided to provide income-tax exemption to the amount received by a taxpayer for medical treatment from employer or from any person for treatment of Covid-19 during FY 2019-20 and subsequent years,” it added.
U.S. approves Roche drug for emergency use against severe COVID-19
The drug can be used to treat patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation, the FDA said, adding studies showed Actemra helped reduce the risk of death and speed recovery.
For months already, the medicine has been given to severely ill COVID-19 patients on a compassionate-use basis, generating hundreds of millions in sales for Roche.
Pfizer halts distribution of anti-smoking drug after finding carcinogen
The drugmaker is recalling a number of lots of anti-smoking drugs. The U.S. drug regulator has in the past reached out to companies whose drugs had N-nitrosodimethylamine (NDMA) over accepted levels.
The Food and Drug Administration (FDA) last year found high levels of NDMA in some versions of the popular diabetes drug metformin. NDMA contamination was responsible for the recall of the heartburn drug Zantac sold by Sanofi SA in 2019.
Third wave of coronavirus unlikely to be as severe as second wave: ICMR Study
Presenting a vaccine ramp-up scenario where 40 percent of the population has received two doses within three months of the second wave peak, and further that the effect of vaccination is (conservatively) to reduce severity of infection by 60 percent, the study said it illustrates how vaccination could substantially reduce the overall burden during the possible third wave.